Other
N359445 · 2026-04-02 — The tariff classification and country of origin of Fluorescein Injection, USP in dosage form
Fluorescein Injection, imported in 500 mg/5 mL vials, is an intravenous diagnostic reagent. It is indicated for fluorescein angiography or angioscopy of the retina and iris vasculature. The applicable subheading for the Fluorescein Injection in dosage form will be 3006.30.5000, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Pharmaceutical goods specified in note 4 to this chapter: Opacifying preparations for X-ray examinations; diagnostic reagents designed to be administered to the patient: Other.” The general rate of duty will be free. The duties cited above are…
N357253 · 2026-01-15 — The tariff classification and country of origin of Indocyanine Green Injection, USP in dosage form
Indocyanine Green Injection, imported in 25 mg vials, is a diagnostic reagent indicated for visualization of vessels, blood flow and tissue perfusion, visualization of extrahepatic biliary ducts, lymphatic mapping of cervical and uterine cancer, and ophthalmic angiography in patients. The applicable subheading for the Indocyanine Green Injection in dosage form will be 3006.30.5000, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Pharmaceutical goods specified in note 4 to this chapter: Opacifying preparations for X-ray examinations; diagnostic reagents designed to…
N349231 · 2025-06-10 — The tariff classification of Gadobutrol Injection in dosage form, from China
Gadobutrol, imported in 604.72 mg, 7.5 mL, 10 mL and 15 mL, is a gadolinium-based contrast agent (GBCA). It is indicated for use with magnetic resonance imaging (MRI) in adult and pediatric patients, including term neonates, to detect and visualize areas with disrupted blood brain barrier and/or abnormal vascularity of the central nervous system. It is also indicated for use with MRI in adult patients to assess the presence and extent of malignant breast disease, magnetic resonance angiography (MRA) and cardiac MRI. The applicable subheading for the Gadobutrol Injection in dosage form will be…
N349232 · 2025-06-10 — The tariff classification of Gadoterate Meglumine Injection in dosage form, from China
Gadoterate Meglumine Injection, imported in 376.9 mg, 10 mL, 15 mL and 20 mL, is a gadolinium-based contrast agent (GBCA). It is indicated for intravenous use with magnetic resonance imaging (MRI) in brain (intracranial), spine and associated tissues in adult and pediatric patients (including term neonates) to detect and visualize areas with disruption of the blood brain barrier (BBB) and/or abnormal vascularity. The applicable subheading for the Gadoterate Meglumine Injection in dosage form will be 3006.30.5000, Harmonized Tariff Schedule of the United States (HTSUS), which provides for…
N314363 · 2020-09-11 — The tariff classification of Chemical Compounds from China
This replaces Ruling Number N313376, dated July 21, 2020, which contained a clerical error. The paragraph pertaining to the eligibility of the individual chemical components, for prototype designation, contained erroneous and incomplete information. A complete corrected ruling follows. CATEGORY: Classification In your letter dated June 17, 2020, and your resubmission dated July 21, 2020, you requested a tariff classification ruling on behalf of your client, Vergent Bioscience, Inc. Request for a binding ruling concerning the Harmonized Tariff Schedule of the United States (HTSUS)…
Not sure this code fits your product? HaiLang AI determines the US HTS code from a description in about a minute.
Classify a product